Nectin-4, a tumour-associated antigen, has been shown to be selectively overexpressed in urothelial cancer, present in approximately 83% of bladder cancers and up to two-thirds of upper tract urothelial cancers, and associated with a poor prognosis [67,68]. This evidence concerns the gene NECTIN4 and urinary bladder carcinoma.